MINI FUTURE SHORT - PFIZER INC | Real-time Euronext Paris 08:34:03 2024-05-22 EDT | ||
| 1.085 EUR | -0.91% |
|
| Current month | -21.51% | ||
| 1 month | -20.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-22 | 1.085 | -0.91% |
| 24-05-21 | 1.095 | +2.82% |
| 24-05-20 | 1.065 | 0.00% |
| 24-05-17 | 1.065 | +1.91% |
| 24-05-16 | 1.045 | +0.97% |
Real-time Euronext Paris
Last update May 22, 2024 at 08:34 am
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | 
BNP Paribas
|
| GD6LB | |
| ISIN | FRBNPP05X0X1 |
| Date issued | 2023-08-14 |
| Strike | 39.98 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.46 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.445 € |
|---|---|
| Lowest since issue | 0.355 € |
| Spread | 0.03 € |
| Spread % | 2.73% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.56
USD
Average target price
31.94
USD
Spread / Average Target
+11.83%
- Stock Market
- Certificates
- GD6LB Certificat